BioSpace News Archive

Kadmon Holdings, Inc. announced that it will voluntarily transfer its stock exchange listing from the New York Stock Exchange to the Nasdaq Global Select Market.

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced publication of data in a murine model of GM1 gangliosidosis (GM1) demonstrating that a single intracerebroventricular injection of an optimized adeno-associated virus (AAV) into the cerebral spinal fluid (CSF) resulted in significant expression of Beta-galactosidase (β-g

Codiak BioSciences, Inc., a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced the pricing of its initial public offering of 5,500,000 shares of its common stock at a public offering price of $15.00 per share, for gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and offering expenses.

Advanced NanoTherapies, Inc., a privately-held medical device company committed to exploring nanotechnology for enhanced drug uptake and sustained retention, today announced it has closed on the final tranche of its seed-round financing for a total of $5.3 million

Physicians’ Education Resource® Brings Psychiatric Disorders to the Forefront During Evolving Times at Annual Psychiatric Times® World CME Conference™ The live, interactive CME virtual conference features premiere access to world-leading psychiatric experts delivering evidence-based presentations on crucial psychiatric topics in 2020

The Leukemia & Lymphoma Society of Canada and Loblaw Companies Limited are pleased to announce this year’s Give a Little, Help a Lot Light The Night campaign has raised $281,874 for Canadians affected by a blood cancer through in-store fundraising at its Superstore and Extra Food locations across the Western provinces and Ontario . Funds

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI).

Influenza A Lab Results Come on Heels of Similar Findings of ClōSYS on the COVID-19 Virus, Just as U.S. Gears Up for Uncertain Flu and Cold Season [13-October-2020] SCOTTSDALE, Ariz. , Oct. 13, 2020 /PRNewswire/ -- Rowpar Pharmaceuticals, Inc., the makers of the ClōSYS brand of toothpastes, mouthwashes and oral sprays, announced today that an in vitro laboratory ana

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has finalized its settlement with the U.S. Department of Justice and the U.S. Department of Health and Human Services. In order to avoid distraction from its core mi

Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz , MD, PhD a